论文部分内容阅读
目的探究静脉血液滤过治疗急性重症胰腺炎的临床效果及安全性。方法选取我院2009年10月至2011年4月间收治的急性重症胰腺炎患者86例作为实验对象,将其随机分为两组,对照组给予常规治疗,实验组在常规治疗的基础上给予静脉血液滤过治疗,对比分析两组患者临床表现指标。结果实验组患者的APACHEⅡ评分明显下降,与对照组相比具有统计学差异(P<0.05)。对照组患者住院时间、治愈率、并发症发生率等方面资料均明显低于实验组,对比P<0.05,具有统计学意义。结论静脉血液滤过治疗急性重症胰腺炎临床效果显著,能够有效改善患者的临床表现指标,改善患者心肺肾脏腑功能,安全性高,值得临床推广应用。
Objective To investigate the clinical effect and safety of venous hemofiltration in the treatment of acute severe pancreatitis. Methods Totally 86 acute pancreatitis patients admitted to our hospital from October 2009 to April 2011 were selected as experimental subjects and randomly divided into two groups. The control group was given routine treatment. The experimental group was given routine treatment Venous hemofiltration treatment, comparative analysis of two groups of patients clinical indicators. Results The APACHE Ⅱ score of experimental group decreased significantly compared with that of control group (P <0.05). Control group patients in hospital time, cure rate, complication rate and other aspects of the data were significantly lower than the experimental group, P <0.05, with statistical significance. Conclusion Venous hemofiltration in the treatment of acute severe acute pancreatitis has a significant clinical effect, which can effectively improve the clinical performance of patients, improve the function of patients with heart, lung, kidney and organs, and is safe and worthy of clinical application.